Activation of cannabinoid receptor 2 alleviates acute lung injury in rats with lipopolysaccharide-induced sepsis.
10.12122/j.issn.1673-4254.2022.09.14
- Author:
Hui Wen KANG
1
;
Shou Fang JIANG
1
;
Qian SONG
1
;
Yi Li ZHANG
2
Author Information
1. School of Public Health, North China University of Science and Technology, Tangshan 063210, China.
2. Health Management Center, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 325000, China.
- Publication Type:Journal Article
- Keywords:
P38 lightning MAPK;
cannabinoid receptor 2;
rats;
sepsis;
tight junction protein
- MeSH:
Acute Lung Injury/metabolism*;
Animals;
Cannabinoids;
Lipopolysaccharides/adverse effects*;
Lung/pathology*;
Occludin/metabolism*;
RNA, Messenger/metabolism*;
Rats;
Rats, Sprague-Dawley;
Receptor, Cannabinoid, CB2;
Receptors, Cannabinoid/metabolism*;
Sepsis/metabolism*;
Tumor Necrosis Factor-alpha/metabolism*;
Water/metabolism*;
p38 Mitogen-Activated Protein Kinases/metabolism*
- From:
Journal of Southern Medical University
2022;42(9):1374-1380
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the protective effect of cannabinoid receptor 2 (CB2) activation against acute lung injury in rats with lipopolysaccharide (LPS)-induced sepsis and explore the underlying mechanism.
METHODS:Forty-eight SD rats were randomly assigned into control group, model group, CB2 agonist group and P38 MAPK inhibitor group (n=12). In the latter 3 groups, the rats received intraperitoneal injection of LPS to induce sepsis, and the control rats were given saline injection. In CB2 agonist group, JWH133 (3 mg/kg) was injected intraperitoneally 30 min before LPS injection; in P38 MAPK inhibitor group, the rats received intraperitoneal injection of SB203580 (5 mg/kg) 30 min prior to JWH133 injection. The changes in lung histopathology, water content, fluid clearance rate, inflammatory factors, pulmonary expressions of CB2 and tight junctionrelated genes, and phosphorylation of P38 MAPK in the lung tissues were examined.
RESULTS:The rat models of sepsis showed severe damage of alveolar structures with significantly decreased fluid clearance rate, lowered pulmonary expressions of CB2, occludin and ZO-1 mRNA and proteins, increased water content in the lung tissue, and increased phosphorylation level of P38 MAPK and TNF-α and IL-1β levels in lung lavage fluid (all P < 0.05). Treatment with JWH133 improved alveolar pathology in the septic rats, but there was still inflammatory infiltration; lung tissue water content, phosphorylation of P38 MAPK, and TNF-α and IL-1β levels in lung lavage fluid were all significantly decreased, and the fluid clearance rate, pulmonary expressions of CB2, occludin and ZO-1 were significantly increased (all P < 0.05). Additional treatment with SB203580 resulted in further improvements of alveolar pathologies, lowered phosphorylation levels of P38 MAPK in the lung tissue and TNF-α and IL-1β levels in lung lavage fluid, and increased the protein expressions of occludin and ZO-1 (P < 0.05) without causing significant changes in mRNA and protein expression of CB2 (P > 0.05).
CONCLUSION:In rats with LPS-induced sepsis, activation of CB2 can inhibit the p38 MAPK signaling pathway, reduce the release of inflammatory factors in the lung tissues, promote tight junction protein expressions, and thus offer protection against acute lung injury.
